Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2012
08/16/2012US20120208811 Aminopyrazole Derivative
08/16/2012US20120208809 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
08/16/2012US20120208798 Tetrahydroquinoline Derivatives And Their Pharmaceutical Use
08/16/2012US20120208790 Ion channel modulators and methods of use
08/16/2012US20120207769 Inhibitors of IAP
08/16/2012US20120207765 Chemokine receptor antagonists and use thereof
08/16/2012US20120207703 Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections
08/16/2012US20120205636 Compound for organic photoelectric device and organic photoelectric device including the same
08/16/2012CA2827005A1 Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
08/16/2012CA2826387A1 Method of inhibiting hamartoma tumor cells
08/16/2012CA2826059A1 Insecticidal compounds
08/16/2012CA2825028A1 Heterocyclic compounds as pi3 kinase inhibitors
08/15/2012EP2487173A1 Amorphous form of dexlansoprazole
08/15/2012EP2487172A1 A Process for the Preparation of (R,S)-Nicotine
08/15/2012EP2487159A1 RorgammaT inhibitors
08/15/2012EP2487154A1 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods
08/15/2012EP2486925A1 Therapeutic agent for cerebral infarction
08/15/2012EP2486034A1 Spirocyclic compounds as modulators of chemokine receptor activity
08/15/2012EP2486033A1 Compounds and compositions as modulators of gpr119 activity
08/15/2012EP2486032A2 Optical resolution of substituted 2-(2- pyridinylmethylsulphinyl)-1h-benzimidazoles
08/15/2012EP2486031A2 Phenylpyri(mi)dinylpyrazoles and their use as fungicides
08/15/2012EP2485736A1 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
08/15/2012EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors
08/15/2012EP2485728A1 Wnt pathway antagonists
08/15/2012EP2485726A1 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
08/15/2012EP2485589A1 Heteroaryl btk inhibitors
08/15/2012EP2324007B1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
08/15/2012EP2276756B9 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
08/15/2012EP2143721B1 Hydrazide compound and harmful arthropod-controlling agent containing the same
08/15/2012EP2102185B1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
08/15/2012EP1976850B1 Novel lanthanide ligands and complexes, and use thereof as contrast agents
08/15/2012EP1960389B1 Compounds which have activity at m1 receptor and their uses in medicine
08/15/2012EP1896450B1 2-substituted benzimidazoles
08/15/2012EP1642899B1 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same
08/15/2012EP1615633B1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/15/2012EP1566378B1 Isoindoline derivative
08/15/2012EP1438295B1 Azole derivatives and pharmaceutical compositions containing them
08/15/2012CN102639527A Novel phenylpyridine derivative and medicinal agent comprising same
08/15/2012CN102639526A L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands
08/15/2012CN102639525A Benzo[c]carbazole compound that has substituent bearing pyridine ring, and organic electroluminescent element
08/15/2012CN102639524A Tetrahydroquinoline indole derivatives and uses thereof
08/15/2012CN102639523A Sustituted (heteroarylmethyl) thiohydantoins as anticancer drugs
08/15/2012CN102639522A Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same
08/15/2012CN102639511A Heterocyclyl substituted arylindenopy-rimidines and their use as highly selective adenosine A2A receptor antagonists
08/15/2012CN102639505A 2-pyridone compounds used as inhibitors of neutrophil elastase
08/15/2012CN102633781A N-alkyl group-3, 6-di-(2-quinoline) vinyl) carbazole and preparation method thereof
08/15/2012CN102633780A Nitric oxide donor with thrombin inhibition effect, as well as preparation method and medical application thereof
08/15/2012CN102633779A Fasudil acetate as well as preparation method and application thereof
08/15/2012CN102633778A Synthesis method of anti-AIDS medicine delavirdine
08/15/2012CN102633777A Dabigatran etexilate 2-ketoglutarate as well as preparation method and application thereof
08/15/2012CN102633776A Method for preparing esomeprazole and sodium salt thereof
08/15/2012CN102633775A Method for preparing alpha-crystal-form imatinib mesylate
08/15/2012CN102633774A Methionine or oxidized methionine modified Clinafloxacin and application thereof
08/15/2012CN102633773A A process for the preparation of (r,s)-nicotine
08/15/2012CN102633732A Phthalazine-like derivative and application thereof
08/15/2012CN102633730A Substituted piperazines as cb1 antagonists
08/15/2012CN102633717A N-acetyl-quinoline-2 (1H) ketone compounds as well as preparation method and application thereof
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102633713A Dabigatran etexilate intermediate, preparation method for same and method for preparing dabigatran etexilate
08/15/2012CN102633709A Main luminophor material and organic light emitting diode containing same
08/15/2012CN102633668A Use of compound in therapeutic drug for diseases related to disorder of transcription factor
08/15/2012CN102351844B Pantoprazole sodium compound and pharmaceutical composition thereof
08/15/2012CN101678020B Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases
08/15/2012CN101558049B Substituted pyrazole and triazole compounds as KSP inhibitors
08/15/2012CN101495463B Seven-membered ring compound, production method thereof and pharmaceutical use thereof
08/15/2012CN101307046B Tripeptidyl peptidase inhibitors
08/15/2012CN101304979B Quinazoline derivative and pharmaceutical
08/15/2012CN101062919B 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
08/14/2012US8242313 Alkoxy enones and enamino ketones and a process for preparation thereof
08/14/2012US8242281 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
08/14/2012US8242280 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia
08/14/2012US8242279 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
08/14/2012US8242273 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine
08/14/2012US8242271 Heterocyclic compounds and uses thereof
08/14/2012US8242175 Class of histone deacetylase inhibitors
08/14/2012US8242157 Benzimidazole derivatives useful as TRPM8 channel modulators
08/14/2012US8242135 Biphenyl derivatives
08/14/2012US8242122 Method and compounds for inhibition of cell death
08/14/2012US8242121 Pyridyl piperidine orexin receptor antagonists
08/14/2012US8242120 Carbocyclic compounds and methods for treating emerging disease, including influenza and Venezuela equine encephalitis virus
08/14/2012US8242117 5-membered heterocycle-based p38 kinase inhibitors
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
08/14/2012US8241680 Nutraceutical product containing anatabine and yerba maté
08/14/2012CA2710182C Pyrimidyl indoline compound
08/14/2012CA2628193C Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
08/14/2012CA2511509C Benzoazolylpiperazine derivatives having vr1 antagonist activity
08/14/2012CA2472021C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/14/2012CA2386069C Indolyl-3-glyoxylic acid derivatives as antitumor agents
08/09/2012WO2012105708A1 Novel crystal of tetrahydronaphthalene compound
08/09/2012WO2012105588A1 Tetrahydroisoquinoline derivative
08/09/2012WO2012104866A1 Chiral 1-(4-methylphenylmethyl)-5-oxo-{n-[(3-t-butoxycarbonyl- aminomethyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion
08/09/2012WO2012104863A2 Process for controlling the content of single enantiomer of omeprazole
08/09/2012WO2012104805A1 Process for the preparation of dexlansoprazole
08/09/2012WO2012104782A1 Pyrrole derivatives used as modulators of alpha7 nachr
08/09/2012WO2012104538A1 Novel 1,5-dihydropyrrol-2-one derivatives for use in the treatment of malaria or other parasitic and fungal diseases
08/09/2012WO2012104338A1 Spiro aminic compounds with nk1 antagonist activity
08/09/2012WO2012103806A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
08/09/2012WO2012024132A3 Solution-processable electron-transport materials and related organic optoelectronic devices
08/09/2012WO2012004811A8 Process for the preparation of 5-substsituted indole derivative
08/09/2012US20120203005 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 1080